摘要
Aldehyde dehydrogenase 2 (ALDH2), an acetaldehyde dehydrogenase in mitochondria, is primarily responsible for metabolizing alcohol-derived acetaldehyde and other endogenous aldehydes. Inactivating ALDH2 rs671 polymorphism is found in up to 8 % of the global population and 40 % of the East Asian population. Recent studies have shown that rs671 SNP mutation in the human ALDH2 gene is associated with an increased risk of metabolic dysfunction-associated steatotic liver diseases (MASLD), but the mechanism remains unclear. Here, we identify the role of ALDH2 in MASLD. Firstly, ALDH2 activity was lower in MASLD patients and the methioninecholine deficiency (MCD) diet induced MASLD model. Secondly, activation of ALDH2 activity with Alda-1 (ALDH2 agonist) attenuated MCD-diet induced hepatic triglyceride (TG) accumulation and steatosis, whereas the opposite result was observed with cyanamide (CYA, ALDH2 inhibitor). Furthermore, ALDH2 deficiency exacerbated hepatic steatosis, inflammation, and fibrosis in the MCD-diet induced mice. RNA sequencing (RNAseq) revealed that oxysterol 7-alpha hydroxylase (Cyp7b1) and the related metabolic pathway significantly changed in the MCD-diet challenged ALDH2-/- mice. In ALDH2-/- mice, the expression of Cyp7b1 was downregulated and FXR/SHP signaling was inhibited, reducing the alternative bile acid (BA) synthetic pathway. In our in vitro experiments, knockdown of ALDH2 exacerbated TG accumulation in hepatocytes, whereas the opposite result was observed with overexpression of ALDH2. Moreover, chenodeoxycholic acid (CDCA) rescued ALDH2 downregulation induced TG accumulation in hepatocytes. Our study reveals that ALDH2 attenuates hepatocyte steatosis by regulating the alternative BA synthesis pathway, and ALDH2 may serve as a potential target for the treatment of MASLD.
| 源语言 | 英语 |
|---|---|
| 页(从-至) | 34-48 |
| 页数 | 15 |
| 期刊 | Free Radical Biology and Medicine |
| 卷 | 212 |
| 早期在线日期 | 12月 2023 |
| DOI | |
| 出版状态 | 已出版 - 20 2月 2024 |
基金资助
This study was supported by the National Natural Science Foundation of China, grant 81970548; Natural Science Foundation of Hubei Province, China, grant 2021CFB046; Medical Science and Technology Innovation Cultivation Fund of Zhongnan Hospital of Wuhan University, grant PTXM2022016; National Natural Science Foundation of China, grant 82300728.
联合国可持续发展目标
此成果有助于实现下列可持续发展目标:
-
可持续发展目标 3 良好健康与福祉
关键词
- Aldehyde dehydrogenase 2
- Metabolic dysfunction-associated steatotic liver
- diseases
- Bile acid
- Methionine-choline deficiency diet
收录
- SCIE
- Scopus
学术指纹
探究 'ALDH2 deficiency exacerbates MCD-diet induced MASLD by modulating bile acid metabolism' 的科研主题。它们共同构成独一无二的学术指纹。引用此
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver